Call for Abstracts 2021

Visit Imfar Website

The INSAR Scientific Program Committee invites proposals for Panels, Posters, Oral Presentations, and Technology Demonstations at the INSAR 2021 Annual Meeting to be held in Boston, Massachusetts, USA on May 05 - 08, 2021.

All abstracts are submitted online. Abstracts may be submitted as (a) part of a Panel, (b) an Oral Presentation, (c) a Poster, or (d) a Technology Demonstration.

Abstract Submission Deadline: Monday, November 16, 2020 (11:59 PM pacific time).

Abstract notifications (panel, oral, and poster) are scheduled to be sent out by Tuesday, March 2, 2021.

Notes for 2021

  1. INSAR 2021 is the 20th Anniversary meeting of the society.
  2. NEW this year – We are hosting our first Hybrid Annual Meeting. The program will include in-person and virtual options for presenters and attendees. As with past annual meetings, all presenters are required to register for the meeting.
  3. During submission you will be able to indicate if you plan to attend the in-person meeting or request to present virtually.
    1. A deadline will be given to notify INSAR if you planned to present “in-person” but need to change to present “remotely”.
    2. All accepted “Remote” presenters must provide a recorded copy of their presentation by the stated deadline.
  4. NEW this year – Expanded ePoster Options. All accepted poster presenters (in-person or remote) will submit an electronic version of their poster for on-demand viewing by registrants. Accepted presenters will upload a PDF copy of the poster, have the option to use an online tool to create "slides" to highlight portions of the poster and can also upload a short video presentation.
  5. The expanded topic areas introduced for the 2019 meeting are being continued to ensure a broad representation of all aspects of current autism research.
  6. The Technology Demonstration session has been expanded to allow greater participation in the interactive demonstrations. Each presenter will have a larger space to accommodate both a poster and demo.
  7. We expect diversity in all proposed panels in viewpoints and approaches, as well as diversity in other domains, including: gender, race, tenure, countries, institutions and disciplines. Panels without significant diversity will not be considered.
  8. Submission should focus on new, unpublished results. Abstracts and panels that do not include unpublished results at the time of submission will not be considered.
  9. Abstracts submitted as part of a panel submission will automatically be considered as an individual submission (oral or poster) if the panel is not accepted, unless the submitter indicates otherwise. Do not submit material more than once (e.g., as part of a panel and as an individual Oral or Poster submission).
  10. Submitters will self-select individual (non-Panel) presentation format from among three options: 1) Oral only, 2) Poster only, or 3) Oral or Poster format. The Program Committee will select the most thematically related and highest rated abstracts to be included in Oral Sessions. If the submitter selects Oral only, and the Program Committee does not select the abstract for an Oral Presentation, the abstract will be withdrawn from consideration. Please indicate Oral or Poster format if there is no objection to the poster format as a default.
  11. There will not be a Late Breaking Abstract submission for this meeting.
  12. The length of the Panel sessions is 2 hours.
  13. The abstract submission fee ($50) will be collected during the submission process. The abstract fee is non-refundable. For Oral or Poster submissions, the fee is waived if any author is a current INSAR member at the time of submission. For Panel submissions, the fee is waived if the Panel Chair is a current INSAR member at the time of submission.
  14. Poster presentations will be scheduled during lunch sessions and early evening sessions. Presenters are expected to stand at their poster during most of the poster session.

Types of Presentations

Panel Submissions. The aim of panels is to present lectures around a common scientific theme of high relevance to autism research. Submissions should consist of 4 linked presentations submitted as a group by a Panel Chair. A Discussant can be included, but is optional. The role of the discussant will be to provide context for the panel, including for non-experts, and/or a discussion integrating concepts raised in the presentations rather than to serve as a 5th presentation.

The Panel Chair should submit a paragraph describing the general theme of the session and the cutting edge science that will be discussed. It is understood that all named speakers will have committed in advance to participate in the panel if selected. The Panel Chair will also provide information about the diversity represented by the group of presenters (see Review Process and Criteria section).

Panel session length is 2 hours. Each talk can be 20 minutes long, with an additional 5 minutes for questions after each presentation, and 10 minutes allotted for the discussant. If there is no discussant, the Panel Chair would determine the best distribution of that time for either presentations or question and answers.

Papers submitted as part of a panel that is not accepted will automatically be considered as an individual submission. If the abstract is reviewed favorably and is determined to stand alone as an individual submission outside a panel, the Program Committee will select oral or poster format. Do not submit material more than once (e.g., as part of a panel and as an individual oral presentation). The submitter can indicate if they do not want the abstract considered for oral or poster presentation. If this option is selected, and the panel isn't accepted, the abstract will be withdrawn from consideration.

Oral Presentations should be data-driven, empirical reports of new findings that have not been previously published or presented elsewhere at the time of submission. Oral presentations will be 10 minutes long with 2 additional minutes for questions. Please avoid using the Oral Presentation format to review the literature or describe published techniques. The Program Committee will evaluate abstracts requested for oral presentations based on their new research content.

Abstracts that are accepted in this format will be grouped into Oral sessions according to common themes by the Program Committee. There are fewer slots for oral presentations than posters. If the submitter selects the "Oral only" format, and the Program Committee does not select the abstract for an Oral Presentation, the abstract will be withdrawn from consideration. Please indicate "Oral or Poster" format if there is no objection to the poster format as a default.

Poster Submissions should be data-driven, empirical reports of new findings that have not been previously published or presented elsewhere at the time of submission.

Poster presentations will be approximately 1.5 hours long.

Technology Demonstration / Poster Submissions should highlight an area of technology and its application to autism spectrum disorder. Preference will be given to those that include empirical data, represent a broad selection of the international community, and include an interactive demonstration of technology.

Review Process and Criteria for All Submissions

Panel, poster, tech demos and oral submissions will be reviewed for scientific merit by independent reviewers. Reviewers are unaware of author identities. Submissions are rated using the following criteria:

  • Importance of findings
  • Clarity
  • Methods
  • Appropriateness of interpretations
  • Relevance of topic to autism research and to meeting attendees
  • For Panels Only: Proposed panels must be diverse in viewpoints and approaches, as well as diverse in other domains, including: gender, race, tenure, countries, institutions and disciplines. Panels with no diversity will not be considered.

Submissions that do not conform to submission instructions will receive lower ratings. In particular,

  1. If the material is submitted more than once (e.g., same content in two different formats), this could result in the submission not being reviewed.
  2. If the abstract lacks sufficient data, for example, an oral presentation that lacks enough content to occupy the 10 minute talk. Avoid lengthy reviews of background literature and published methods.
  3. Abstracts should represent research that has already been carried out and has produced statistically reliable findings but which has not yet been published (at the time of submission). Abstracts that are promissory notes of research that will be conducted in the future will receive lower scores even if the topic is of interest.
  4. If reviewers have significant ethical concerns.

Steps and Instructions:

Abstract Preparation

  1. Report original research.
    • All submissions should provide "new" information. Oral and Poster submissions should not have been published or presented previously at the time of submission. Panels may include previously published information, but it is expected that they will also provide new, unpublished data as well.
  2. Provide Background, Objectives, Methods, Results, and Conclusions with enough information to allow the reviewer to assess the value of each of these categories. Indicate if the research is exploratory. Rationale, significance of results and general principles should be explained. Methods should be very brief. It is not satisfactory to say, "The results will be discussed."
  3. Highlight examples of scientific rigor (sample sizes, replication, blinding and controls used).
  4. Provide biological variables as appropriate (age, sex, species, etc.).
  5. State units of measure using standard abbreviations.
    • When using other abbreviations, fully spell out once and indicate the abbreviation in parentheses that will be used going forward.

Guidelines for Submissions

  1. Submission of an abstract for presentation at the INSAR Annual Meeting is predicated on the following:
    • Any work with human or animal subjects reported in the abstract complies with the guiding policies and principles for experimental procedures endorsed by the National Institutes of Health.
    • Each author has given consent to appear as an author. Each author will automatically receive notice of abstract submission.
  2. Disclosure of Conflicts of Interest. Any real or perceived financial conflict of interest (COI), such as royalties, pharmaceutical relationships, case litigation, etc., of each investigator must be reported. Any potential for financial gain that may be derived from reported work may constitute a potential conflict of interest. The final step in the process will be the requirement for each author to log into the site and sign the personal COI statement. This must be done by Monday, November 23, 2020 at 11:59 PM pacific time. Failure to declare a real or perceived COI, or COI statements from any co-authors that are incomplete at the disclosure deadline, will result in withdrawal of the abstract from meeting presentation, and the Program and Abstract books as well as a prohibition in submitting an abstract to the INSAR Annual Meeting for the following year. All COIs must be displayed in oral and poster presentations and they will be identified in the online program.
  3. Data Presentation: Presentation of research at the meeting must be substantively identical to that summarized in the abstract. Including new data collected after submission is encouraged.
  4. All authors must accept and follow INSAR's embargo policy.
    • Information submitted to the Annual Meeting as an abstract for oral or poster presentation is embargoed for the purpose of press releases until after the presentation. The Program Committee will select a small group of abstracts for inclusion in a press book and INSAR will arrange for information release and press conferences during the meeting. Press policies may be viewed on the INSAR website.
  5. Online submission is required.
    • Submissions are only accepted through the online abstract system.
    • Submissions are only accepted in English.
    • A profile on the INSAR website is required to access the online submitter. INSAR members and recent meeting attendees already have a login, others can create one.
    • An individual may submit as the first author or presenter once for each submission type (oral, poster, panel).
    • For members of INSAR, there is no fee to submit abstracts. Non-members will be charged a $50 processing fee during the submission process. This fee is non-refundable.
      1. Payment must be rendered by credit card (MasterCard, Visa, or American Express only). Double-check credit card information for accuracy.
      2. Purchase orders are not accepted.
    • Abstract submission does not include registration for the annual meeting; presenting authors must register to attend the annual meeting.
    • All submissions should provide "new" information. Oral and Poster submissions should not have been published or presented previously at the time of submission. Panels may include previously published information, but it is expected that they will also provide new, unpublished data as well.
    • Abstracts must be submitted through the INSAR Annual Meeting online submitter by Monday, November 16, 2020 at 11:59 PM pacific time.
  6. TO SUBMIT AN ABSTRACT FOR AN ORAL PRESENTATION OR POSTER:

    The text of abstract submissions must:

    • Be 500 words or less.
    • Include the following sub-headings: Background, Objectives, Methods, Results, Conclusions -- with enough information to allow the reviewer to assess the value of each of these categories.
    • Not include the authors' names and affiliations.
    • Graphics (tables/figures) are optional. They do not count toward the 500 word limit. A maximum of two graphics are allowed (2 tables, 2 figures, or one of each), incorporated into a single file. Upload the graphics file using one of the following file formats: .jpg, .gif, .png.
    • For Tech Demo submissions:
      1. Note if the presentation will include a live demo at the meeting.
      2. If so, briefly describe the demo.
  7. TO SUBMIT A PANEL:

    Enter both a summary of the overall panel theme, information about diversity represented, and an abstract for each proposed talk in the panel.

    • Panels require a Panel Chair who is responsible for the content within the panel. The Panel Chair can also serve as a speaker within the panel.
    • Individual authors will be sent an email with a link to their specific abstract. It is up to the Panel Chair to decide whether he/she would like to submit all abstracts or ask each author to submit his/her own abstract for the panel.
    • The submitter of each abstract can indicate if they do not want their specific abstract considered for oral or poster presentation in the case of the panel not being accepted.
    • A discussant can be included, but is optional. The discussant should be identified at the time the panel is submitted; no abstract is submitted for the discussant. The role of the discussant is to provide context for the panel, including for non-experts, and/or a discussion integrating concepts raised in the presentations, rather than to serve as a 5th presentation.

    Panels will be evaluated as a whole. If any abstract within the panel is incomplete, the panel will be considered incomplete.

    The text of Panel submissions must:

    • Include a paragraph (200 words or less) describing the overall theme of the panel, followed by a 500 word or less abstract for each presentation within the panel.
    • Include the following sub-headings in each abstract: Background, Objectives, Methods, Results, Conclusions -- with enough information to allow the reviewer to assess the value of each of these categories.
    • Not include the authors' names and affiliations.

    Note: ALL ABSTRACTS WILL BE PRINTED EXACTLY AS THEY ARE SUBMITTED. Therefore we recommend that you compose the text of the abstract in a separate document before beginning the online submission process. Check the spelling and grammar of the text before submitting it. The conference organizers will not edit any portion of abstracts (e.g., title, authors, affiliations, spelling errors).

    As soon as you have submitted the title of your presentation you will automatically receive an email (from insar@confex.com) that includes a password-protected hyperlink. If you must interrupt the submission process before finishing it, you can resume at any time by clicking on the hyperlink in that email.

Confirmation

You will have a chance to look over the submission to make sure all is complete.

General Instructions

No names or titles should be included in the abstract text. Names will be automatically hidden during the abstract review process and will be automatically inserted and properly formatted upon publication.

Presenting authors will be automatically informed of the unique ID numbers and passwords assigned to their abstracts. Abstracts may be viewed and modified at any time between submission and the deadline, using the assigned ID# and password.

Technical Support

Contact technical support for help in submitting an abstract online.


Submission Categories:

Choose the category that is the best fit for your research. After you start a submission, select a "second preferred category" and "third preferred category" from the options listed if your work spans three different categories.

Begin a submission to the following

ADULT OUTCOME: MEDICAL, COGNITIVE, BEHAVIORAL, SOCIAL, ADAPTIVE, VOCATIONAL

Deadline for Submissions: Monday, November 16, 2020

AFFECTIVE NEUROSCIENCE

Deadline for Submissions: Monday, November 16, 2020

ANIMAL MODELS

Deadline for Submissions: Monday, November 16, 2020

BEHAVIORAL GENETICS

Deadline for Submissions: Monday, November 16, 2020

BEHAVIORAL NEUROSCIENCE

Deadline for Submissions: Monday, November 16, 2020

BIOMARKERS (MOLECULAR, PHENOTYPIC, NEUROPHYSIOLOGICAL, ETC)

Deadline for Submissions: Monday, November 16, 2020

BIOMARKERS / EARLY DEVELOPMENT

Deadline for Submissions: Monday, November 16, 2020

CELLULAR MODELS/STEM CELLS

Deadline for Submissions: Monday, November 16, 2020

CELLULAR NEUROSCIENCE

Deadline for Submissions: Monday, November 16, 2020

CLINICAL GENETICS

Deadline for Submissions: Monday, November 16, 2020

CLINICAL TRIAL DESIGN

Deadline for Submissions: Monday, November 16, 2020

CLINICAL TRIAL ENDPOINTS

Deadline for Submissions: Monday, November 16, 2020

COGNITION: ATTENTION, LEARNING, MEMORY

Deadline for Submissions: Monday, November 16, 2020

COGNITIVE NEUROSCIENCE

Deadline for Submissions: Monday, November 16, 2020

COMMUNICATION AND LANGUAGE

Deadline for Submissions: Monday, November 16, 2020

COMMUNICATION AND LANGUAGE / NEUROIMAGING

Deadline for Submissions: Monday, November 16, 2020

DIAGNOSTIC, BEHAVIORAL, SENSORY AND INTELLECTUAL SCREENING AND ASSESSMENT

Deadline for Submissions: Monday, November 16, 2020

DRUG DISCOVERY AND DEVELOPMENT

Deadline for Submissions: Monday, November 16, 2020

EARLY DEVELOPMENT (< 48 MONTHS)

Deadline for Submissions: Monday, November 16, 2020

EARLY PHASE DRUG DISCOVERY

Deadline for Submissions: Monday, November 16, 2020

EDUCATION

Deadline for Submissions: Monday, November 16, 2020

EMOTION

Deadline for Submissions: Monday, November 16, 2020

EPIDEMIOLOGY/POPULATION STUDIES

Deadline for Submissions: Monday, November 16, 2020

EPIGENETICS

Deadline for Submissions: Monday, November 16, 2020

ETHICS

Deadline for Submissions: Monday, November 16, 2020

FAMILY ISSUES AND STAKEHOLDER EXPERIENCES

Deadline for Submissions: Monday, November 16, 2020

GASTROINTESTINAL (GI)

Deadline for Submissions: Monday, November 16, 2020

GASTROINTESTINAL (GI) / IMMUNOLOGY

Deadline for Submissions: Monday, November 16, 2020

GENETICS

Deadline for Submissions: Monday, November 16, 2020

IMMUNOLOGY

Deadline for Submissions: Monday, November 16, 2020

INTERNATIONAL AND CROSS-CULTURAL PERSPECTIVES

Deadline for Submissions: Monday, November 16, 2020

INTERVENTIONS - NON-PHARMACOLOGIC - INFANT, TODDLER, AND PRESCHOOL

Deadline for Submissions: Monday, November 16, 2020

INTERVENTIONS - NON-PHARMACOLOGIC - SCHOOL-AGE, ADOLESCENT, ADULT

Deadline for Submissions: Monday, November 16, 2020

INTERVENTIONS - PHARMACOLOGIC

Deadline for Submissions: Monday, November 16, 2020

INVITED, KEYNOTE SPEAKERS, AWARDS

Deadline for Submissions: Monday, November 16, 2020

LATE PHASE DRUG DEVELOPMENT

Deadline for Submissions: Monday, November 16, 2020

MEDICAL AND PSYCHIATRIC COMORBIDITY

Deadline for Submissions: Monday, November 16, 2020

MOLECULAR GENETICS

Deadline for Submissions: Monday, November 16, 2020

MOLECULAR NEUROSCIENCE

Deadline for Submissions: Monday, November 16, 2020

NEUROANATOMY

Deadline for Submissions: Monday, November 16, 2020

NEUROCHEMISTRY

Deadline for Submissions: Monday, November 16, 2020

NEUROIMAGING

Deadline for Submissions: Monday, November 16, 2020

NEUROLOGICAL FINDINGS

Deadline for Submissions: Monday, November 16, 2020

NEUROLOGY

Deadline for Submissions: Monday, November 16, 2020

NEUROPHYSIOLOGY/ELECTROPHYSIOLOGY

Deadline for Submissions: Monday, November 16, 2020

NEUROPSYCHOLOGY

Deadline for Submissions: Monday, November 16, 2020

NEUROSCIENCE: AFFECTIVE, BEHAVIORAL, COGNITIVE

Deadline for Submissions: Monday, November 16, 2020

NOVEL THERAPEUTIC APPROACHES (GENE, PROTEIN OR RNA TARGETED THERAPIES)

Deadline for Submissions: Monday, November 16, 2020

PATIENTS, FAMILIES, AND CLINICAL SERVICES

Deadline for Submissions: Monday, November 16, 2020

PEDIATRICS

Deadline for Submissions: Monday, November 16, 2020

POSTMORTEM STUDIES

Deadline for Submissions: Monday, November 16, 2020

RARE GENETIC DISORDERS

Deadline for Submissions: Monday, November 16, 2020

SENSORY PHYSIOLOGY

Deadline for Submissions: Monday, November 16, 2020

SENSORY, MOTOR, AND REPETITIVE BEHAVIORS AND INTERESTS

Deadline for Submissions: Monday, November 16, 2020

SERVICE DELIVERY/SYSTEMS OF CARE

Deadline for Submissions: Monday, November 16, 2020

SOCIAL COGNITION AND SOCIAL BEHAVIOR

Deadline for Submissions: Monday, November 16, 2020

SOCIAL NEUROSCIENCE

Deadline for Submissions: Monday, November 16, 2020

STATISTICAL GENETICS

Deadline for Submissions: Monday, November 16, 2020

TECHNOLOGICAL APPROACHES

Deadline for Submissions: Monday, November 16, 2020

TECHNOLOGY DEMONSTRATION / DEVICES

Deadline for Submissions: Monday, November 16, 2020